A new analysis points to a performance gap in AI claims from large U.S. health insurers, arguing that operational reality is slowing adoption. The reporting describes how insurers including UnitedHealth Group and CVS Health have continued to invest in AI, while the practical outcomes for clinical and administrative workflows face friction. The piece frames a reality check: despite scaling AI initiatives, insurers still have to meet accuracy, governance, and integration standards across complex payer operations. The development matters for biotech partners working on AI-enabled diagnostics, trial operations, and clinical data platforms, because payer validation often determines whether AI capabilities become broadly deployable.